StocksHealthcareLIVN

LIVN

LivaNova PLC
NasdaqResearch view
Healthcare · Electromedical & Electrotherapeutic Apparatus · Mid-cap · SEC EDGAR FY 2025-12-31

Price history

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$4.3B
Enterprise Value$4.1B
Income$-242.5M
Sales$1.4B
Book/sh$21.78
Cash/sh$11.54
Dividend TTM
Payout
Employees
IPO
Quick Ratio1.16
Current Ratio1.36
Debt/Eq0.34
EPS (ttm)$-4.45
EPS this Y-483.6%
EPS past 3/5Y
Sales past 3/5Y10.8%
EPS Y/Y TTM-483.6%
Sales Y/Y TTM10.7%
Shs Outstand55.09M
ROA-9.3%
ROE-20.2%
ROIC22.5%
Gross Margin67.7%
Oper. Margin14.4%
Profit Margin-17.5%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$1.0B
2021
$1.0B
2022
$1.2B
2023
$1.3B
2024
$1.4B
2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet
0%40%80%68%14%-17%FY21FY22FY23FY24FY25

FY25 cash-flow waterfall

Capital-light: capex is $81.0M against $254.3M operating cash
$254.3MOperating CF$81.0M− Capex$173.3MFree CF
COMMUNITY · $LIVN0 theses
POST YOUR TAKE →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.